Jpmorgan Chase & CO Electro Core, Inc. Transaction History

Jpmorgan Chase & CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.27 - $0.61 $1,111 - $2,511	-4,117 Reduced 99.61%	16 $0
Q1 2022 May 11, 2022	BUY	$0.5 - $0.88 $2,058 - $3,622	4,117 Added 25731.25%	4,133 $2,000
Q3 2021 Nov 12, 2021	BUY	$0.93 - $1.18 $14 - $18	16 New	16 $0

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $1.09B
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.